Brief: Uscom BP Plus in Final Review Phase of NMPA in China
29/03/2021 02:48
March 29 (Reuters) - Uscom Ltd UCM.AX :
* NOTIFIED THAT ITS BP+ NON- INVASIVE CENTRAL BLOOD PRESSURE
MONITOR, ENTERED FINAL REVIEW PHASE OF NMPA REGULATORY APPROVAL
* FINAL NMPA APPROVAL IS EXPECTED TO BY APRIL TO AUGUST,
2021
Source text for Eikon: ID:nASX4FzD1n
Further company coverage: UCM.AX
((Reuters.Briefs@thomsonreuters.com;))
Recent news on USCOM
See all newsBrief: Uscom To Sell Whole Of Businesses, Assets To Axo Medtech Vcc
Brief: Uscom Arranges A$1 Million Loan From Its Executive Chairman
Brief: Uscom Says Non-Renounceable Rights Issue Offer
Brief: Uscom Ltd Says Confirmed Conducting Off-Market Equal Access Share Buy-Back
Brief: Uscom Establishes Sale Facility For Less Than Marketable Parcels Of Shares In Co